Specifically, the publication with second highest impact factor in the “science” category is Acta Crystallographica – Section A, knocking none other than the New England Journal of Medicine from the runner’s up position. This title’s impact factor rocketed up to 49.926 this year, more than 20-fold higher than last year.
On Tuesday, June 15, FDA launched a web page where you can find summaries of safety information about recently approved drugs and a brief discussion of any steps FDA may be taking to address any identified safety issues. New drugs approved after September 27, 2007 will receive a safety summary within roughly two years of approval. The summaries address safety risks that were not identified during a drug’s development or prior to FDA approval. FDA plans to publish summaries on a quarterly basis.
- Medical Free/Libre and Open Source Software: Medfloss.org provides a comprehensive and structured overview of Free/Libre and Open Source Software (FLOSS) projects for the health care domain. Moreover it offers an open content platform to foster the exchange of ideas, knowledge and experiences about these projects.
- 23andme – yes, me – part 3: A detailed review of what the genetic report of 23andme looks like.
- Did you know that there is an Open (Participatory) Peer-Review at the Journal of Medical Internet Research? You can sign up as peer-reviewer.